HYDROCORTISONE SUBSTIPHARM 100 mg, lyophilizate (vial) and solution for parenteral use oral lyophilisate
Active ingredients: Cortisol, Hydrocortisone hemisuccinate
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Lyophilizate and solution for parenteral useoral lyophilisateintramusculaire;intraveineuse
Marketing discontinued
Package details
Original BDPM fields are shown in French.
- Official name
- HYDROCORTISONE SUBSTIPHARM 100 mg, lyophilisat (flacon) et solution pour usage parentéral
- Pharmaceutical form
- lyophilisat et solution pour usage parentéral
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 1 flacon(s) en verre de 1 lyophilisat(s) - 1 ampoule(s) en verre de 2 ml
- Marketing authorisation holder
- SUBSTIPHARM
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 21 May 2013
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62735380CIP73357234CIP133400933572341Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| HYDROCORTISONElyophilisat | 100 mg · un flacon | FT |
| HYDROCORTISONE (HYDROGÉNOSUCCINATE D')lyophilisat | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.